Drug discovery in China: Challenges and opportunities
文献类型：期刊论文
| 作者 | Wang, Ling1; Ding, Ke3; Yang, Shengyong4; Yang, Zhen5; Zhang, Ao6 ; Zhou, Demin1,2,7
|
| 刊名 | National Science Review
 |
| 出版日期 | 2018-09-01 |
| 卷号 | 5期号:5页码:768-773 |
| ISSN号 | 20955138 |
| DOI | 10.1093/nsr/nwy085 |
| 文献子类 | Article |
| 英文摘要 | Human history is also a chronicle of battling against diseases.Thanks to the rapid advancement of life science and biotechnologies such as gene editing and deep sequencing, recent decades have seen more and more untreatable illnesses on the verge of being conquered. However, an efficient drug-innovation system involves multiple driving forces-policy stimulation and commercial interests play important roles, besides advances in science and technology.Therefore, establishing the synergism among various driving forces is essential for new drug discovery and development. As the most populous country in the world, China has the largest population of a broad spectrum of diseases, offering a unique environment for research and development in biomedicine and disease therapies. Although most pharmaceutical companies in China have been focused on making generic drugs in the past, some efforts in developing first-in-class drugs are paying off, especially in the small-molecule drugs. What are the emerging trends in drug discovery?What does Artificial Intelligence (AI) bring to drug development and medical treatments? In the future, how will China take advantage of abundant resources and proactive policies to accelerate drug development? Recently, NSR organized a forum focusing on these issues, with the attendance of five distinguished domestic pharmaceutical scientists. |
| 语种 | 英语 |
| 出版者 | Oxford University Press |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/266964]  |
| 专题 | 药物化学研究室 |
| 作者单位 | 1.Shanghai, China 2.School of Pharmaceutical Sciences, Peking University, Beijing, China; 3.College of Pharmacy, Jinan University, Jinan, China; 4.State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China; 5.Department of Chemistry, Peking University, Beijing, China; 6.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 7.Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, China; |
| 推荐引用方式 GB/T 7714 | Wang, Ling,Ding, Ke,Yang, Shengyong,et al. Drug discovery in China: Challenges and opportunities[J]. National Science Review,2018,5(5):768-773. |
| APA | Wang, Ling,Ding, Ke,Yang, Shengyong,Yang, Zhen,Zhang, Ao,&Zhou, Demin.(2018).Drug discovery in China: Challenges and opportunities.National Science Review,5(5),768-773. |
| MLA | Wang, Ling,et al."Drug discovery in China: Challenges and opportunities".National Science Review 5.5(2018):768-773. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。